TY - JOUR
T1 - Prevention and treatment of infectious diseases in migrants in Europe in the era of universal health coverage
AU - Baggaley, Rebecca F
AU - Zenner, Dominik
AU - Bird, Paul
AU - Hargreaves, Sally
AU - Griffiths, Chris
AU - Noori, Teymur
AU - Friedland, Jon S
AU - Nellums, Laura B
AU - Pareek, Manish
N1 - Funding Information: RFB is supported by a Wellcome Trust Institutional Strategic Support Fund Fellowship (204801/Z/16/Z). MP is supported by a National Institute for Health Research (NIHR) Development and Skills Enhancement Award and also acknowledges funding from the NIHR Leicester Biomedical Research Centre and UK Research and Innovation. SH acknowledges funding from the NIHR (NIHR Advanced Fellowship NIHR300072), The Academy of Medical Sciences (SBF005\1111), Novo Nordisk Foundation and La Caixa Foundation (Mobility—Global Medicine and Health Research grant), and WHO. JSF acknowledges funding from the Medical Research Council (UK) and Rosetrees Trust for research on migrant health. CG is supported by the NIHR Applied Research Collaboration North Thames. The views expressed in this publication are those of the authors and not necessarily those of the funders. The funders played no role in the conception or writing of this Viewpoint nor in the decision to submit for publication. Publisher Copyright: © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
PY - 2022/10
Y1 - 2022/10
N2 - Some subpopulations of migrants to Europe are generally healthier than the population of the country of settlement, but are at increased risk of key infectious diseases, including tuberculosis, HIV, and viral hepatitis, as well as under- immunisation. Infection screening programmes across Europe work in disease silos with a focus on individual diseases at the time of arrival. We argue that European health-care practitioners and policy makers would benefit from developing a framework of universal health care for migrants, which proactively offers early testing and vaccinations by delivering multi-disease testing and catch-up vaccination programmes integrated within existing health systems. Such interventions should be codeveloped with migrant populations to overcome barriers faced in accessing services. Aligning policies with the European Centre for Disease Prevention and Control guidance for health care for migrants, community-based preventive health-care programmes should be delivered as part of universal health care. However, effective implementation needs appropriate funding, and to be underpinned by high-quality evidence.
AB - Some subpopulations of migrants to Europe are generally healthier than the population of the country of settlement, but are at increased risk of key infectious diseases, including tuberculosis, HIV, and viral hepatitis, as well as under- immunisation. Infection screening programmes across Europe work in disease silos with a focus on individual diseases at the time of arrival. We argue that European health-care practitioners and policy makers would benefit from developing a framework of universal health care for migrants, which proactively offers early testing and vaccinations by delivering multi-disease testing and catch-up vaccination programmes integrated within existing health systems. Such interventions should be codeveloped with migrant populations to overcome barriers faced in accessing services. Aligning policies with the European Centre for Disease Prevention and Control guidance for health care for migrants, community-based preventive health-care programmes should be delivered as part of universal health care. However, effective implementation needs appropriate funding, and to be underpinned by high-quality evidence.
UR - http://www.scopus.com/inward/record.url?scp=85138821538&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/S2468-2667(22)00174-8
DO - https://doi.org/10.1016/S2468-2667(22)00174-8
M3 - Review article
C2 - 36037808
SN - 2468-2667
VL - 7
SP - e876-e884
JO - The Lancet. Public health
JF - The Lancet. Public health
IS - 10
ER -